GLG News by Cosmetic Dermatologists (US)
Request a free trial
June 4, 2007Modus product-?efficacy
Analysis of: No Hydroquinone, Means No Worries for Modus. Dr.’s Applaud Europe’s New Import To Fight Signs of Aging | www.rushprnews.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Already here....
Analysis of: Getting a Discount on Plastic Surgery | online.wsj.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
New Organiceuticals May Help Bring Back Beauty!
Analysis of: http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin | www.nytimes.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: GLG Expert Contributor
Couldn't agree more
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
May 24, 2007FDA Hydroquinone ban may be premature
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Non-Invasive Screening of the Skin
Analysis of: New tool allows noninvasive screening of skin lesions | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Pulsed Dye Vs Excimer Laser for Psoriasis
Analysis of: Psoriasis Challenge: pulsed dye vs. excimer lasers | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
For wounds, it is going to happen
Analysis of: Home telemonitoring works, study claims | www.healthcareitnews.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
May 4, 2007Ceragenix Epiceram product phase 4 results positive
Analysis of: Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints | www.irconnect.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Previous Page : 1 2 3 4 5 6 7 8 9 Next51 to 60 of 81
More GLG News in
Healthcare
ADAGIO Trial Results Show Teva's AZILECT(R) 1 Mg Tablets Slow Progression Of Parkinson's Disease
www.medicalnewstoday.com
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
www.therapeuticsdaily.com
Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
jco.ascopubs.org
Healthways' Guidance Not So Healthy
www.forbes.com
Cell Genesys Ends Clinical Trials For Prostate Cancer Treatment
online.wsj.com
Azilect
September 2, 2008
Byetta Saves Lives
September 2, 2008
The Devil Is in the Details
September 1, 2008
Dangers of Methadone Usage
August 28, 2008
Healthways A Market Downturn and Results
August 26, 2008

